Literature DB >> 28628199

Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.

Mario Niepel1, Marc Hafner1, Mirra Chung1, Peter K Sorger1.   

Abstract

Measuring the potencies of small-molecule drugs in cell lines is a critical aspect of preclinical pharmacology. Such experiments are also prototypical of high-throughput experiments in multi-well plates. The procedure is simple in principle, but many unrecognized factors can affect the results, potentially making data unreliable. The procedures for measuring drug response described here were developed by the NIH LINCS program to improve reproducibility. Key features include maximizing uniform cell growth during the assay period, accounting for the effects of cell density on response, and correcting sensitivity measures for differences in proliferation rates. Two related protocols are described: one involves an endpoint measure well-suited to large-scale studies and the second is a time-dependent measurement that reveals changes in response over time. The methods can be adapted to other types of plate-based experiments. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  GR50; GRmax; cancer; dose-response; drug resistance; drug sensitivity; growth rate inhibition

Mesh:

Substances:

Year:  2017        PMID: 28628199      PMCID: PMC5538315          DOI: 10.1002/cpch.21

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  34 in total

1.  High-throughput assessment of Mammalian cell viability by determination of adenosine triphosphate levels.

Authors:  Nicola Tolliday
Journal:  Curr Protoc Chem Biol       Date:  2010-09-01

2.  Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

Authors:  Timothy R Wilson; Jane Fridlyand; Yibing Yan; Elicia Penuel; Luciana Burton; Emily Chan; Jing Peng; Eva Lin; Yulei Wang; Jeff Sosman; Antoni Ribas; Jiang Li; John Moffat; Daniel P Sutherlin; Hartmut Koeppen; Mark Merchant; Richard Neve; Jeff Settleman
Journal:  Nature       Date:  2012-07-26       Impact factor: 49.962

3.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

4.  Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.

Authors:  Matthew D Hall; Katherine A Telma; Ki-Eun Chang; Tobie D Lee; James P Madigan; John R Lloyd; Ian S Goldlust; James D Hoeschele; Michael M Gottesman
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

5.  A one-step imaging assay to monitor cell cycle state and apoptosis in mammalian cells.

Authors:  Yangzhong Tang
Journal:  Curr Protoc Chem Biol       Date:  2014-03-14

Review 6.  Kinetic resistance to anticancer agents.

Authors:  M T Dimanche-Boitrel; C Garrido; B Chauffert
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Circumvention of confluence-dependent resistance in a human multi-drug-resistant colon-cancer cell line.

Authors:  C Garrido; B Chauffert; D Pinard; F Tibaut; P Genne; M Assem; M T Dimanche-Boitrel
Journal:  Int J Cancer       Date:  1995-06-09       Impact factor: 7.396

8.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes.

Authors:  Anne E Carpenter; Thouis R Jones; Michael R Lamprecht; Colin Clarke; In Han Kang; Ola Friman; David A Guertin; Joo Han Chang; Robert A Lindquist; Jason Moffat; Polina Golland; David M Sabatini
Journal:  Genome Biol       Date:  2006-10-31       Impact factor: 13.583

9.  Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research.

Authors:  Verena M C Quent; Daniela Loessner; Thor Friis; Johannes C Reichert; Dietmar W Hutmacher
Journal:  J Cell Mol Med       Date:  2010-01-15       Impact factor: 5.310

10.  A combinatorial strategy for treating KRAS-mutant lung cancer.

Authors:  Eusebio Manchado; Susann Weissmueller; John P Morris; Chi-Chao Chen; Ramona Wullenkord; Amaia Lujambio; Elisa de Stanchina; John T Poirier; Justin F Gainor; Ryan B Corcoran; Jeffrey A Engelman; Charles M Rudin; Neal Rosen; Scott W Lowe
Journal:  Nature       Date:  2016-06-22       Impact factor: 49.962

View more
  11 in total

Review 1.  The impact of non-genetic heterogeneity on cancer cell death.

Authors:  Zintis Inde; Scott J Dixon
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-18       Impact factor: 8.250

2.  Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.

Authors:  Marc Hafner; Mario Niepel; Peter K Sorger
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

3.  Dose-Response Metabolomics To Understand Biochemical Mechanisms and Off-Target Drug Effects with the TOXcms Software.

Authors:  Cong-Hui Yao; Lingjue Wang; Ethan Stancliffe; Miriam Sindelar; Kevin Cho; Weitong Yin; Yahui Wang; Gary J Patti
Journal:  Anal Chem       Date:  2020-01-07       Impact factor: 6.986

Review 4.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.

Authors:  Alexandra B Keenan; Sherry L Jenkins; Kathleen M Jagodnik; Simon Koplev; Edward He; Denis Torre; Zichen Wang; Anders B Dohlman; Moshe C Silverstein; Alexander Lachmann; Maxim V Kuleshov; Avi Ma'ayan; Vasileios Stathias; Raymond Terryn; Daniel Cooper; Michele Forlin; Amar Koleti; Dusica Vidovic; Caty Chung; Stephan C Schürer; Jouzas Vasiliauskas; Marcin Pilarczyk; Behrouz Shamsaei; Mehdi Fazel; Yan Ren; Wen Niu; Nicholas A Clark; Shana White; Naim Mahi; Lixia Zhang; Michal Kouril; John F Reichard; Siva Sivaganesan; Mario Medvedovic; Jaroslaw Meller; Rick J Koch; Marc R Birtwistle; Ravi Iyengar; Eric A Sobie; Evren U Azeloglu; Julia Kaye; Jeannette Osterloh; Kelly Haston; Jaslin Kalra; Steve Finkbiener; Jonathan Li; Pamela Milani; Miriam Adam; Renan Escalante-Chong; Karen Sachs; Alex Lenail; Divya Ramamoorthy; Ernest Fraenkel; Gavin Daigle; Uzma Hussain; Alyssa Coye; Jeffrey Rothstein; Dhruv Sareen; Loren Ornelas; Maria Banuelos; Berhan Mandefro; Ritchie Ho; Clive N Svendsen; Ryan G Lim; Jennifer Stocksdale; Malcolm S Casale; Terri G Thompson; Jie Wu; Leslie M Thompson; Victoria Dardov; Vidya Venkatraman; Andrea Matlock; Jennifer E Van Eyk; Jacob D Jaffe; Malvina Papanastasiou; Aravind Subramanian; Todd R Golub; Sean D Erickson; Mohammad Fallahi-Sichani; Marc Hafner; Nathanael S Gray; Jia-Ren Lin; Caitlin E Mills; Jeremy L Muhlich; Mario Niepel; Caroline E Shamu; Elizabeth H Williams; David Wrobel; Peter K Sorger; Laura M Heiser; Joe W Gray; James E Korkola; Gordon B Mills; Mark LaBarge; Heidi S Feiler; Mark A Dane; Elmar Bucher; Michel Nederlof; Damir Sudar; Sean Gross; David F Kilburn; Rebecca Smith; Kaylyn Devlin; Ron Margolis; Leslie Derr; Albert Lee; Ajay Pillai
Journal:  Cell Syst       Date:  2017-11-29       Impact factor: 10.304

5.  RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity.

Authors:  John D O'Connor; Ian M Overton; Stephen J McMahon
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

6.  GRcalculator: an online tool for calculating and mining dose-response data.

Authors:  Nicholas A Clark; Marc Hafner; Michal Kouril; Elizabeth H Williams; Jeremy L Muhlich; Marcin Pilarczyk; Mario Niepel; Peter K Sorger; Mario Medvedovic
Journal:  BMC Cancer       Date:  2017-10-24       Impact factor: 4.430

7.  Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.

Authors:  Mario Niepel; Marc Hafner; Qiaonan Duan; Zichen Wang; Evan O Paull; Mirra Chung; Xiaodong Lu; Joshua M Stuart; Todd R Golub; Aravind Subramanian; Avi Ma'ayan; Peter K Sorger
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

8.  A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.

Authors:  Mario Niepel; Marc Hafner; Caitlin E Mills; Kartik Subramanian; Elizabeth H Williams; Mirra Chung; Benjamin Gaudio; Anne Marie Barrette; Alan D Stern; Bin Hu; James E Korkola; Joe W Gray; Marc R Birtwistle; Laura M Heiser; Peter K Sorger
Journal:  Cell Syst       Date:  2019-07-10       Impact factor: 10.304

9.  Cytotoxic and Antioxidant Effects of Phoenix dactylifera L. (Ajwa Date Extract) on Oral Squamous Cell Carcinoma Cell Line.

Authors:  Khushboo Shahbaz; Jawaad Ahmed Asif; Tang Liszen; Asma Abdullah Nurul; Mohammad Khursheed Alam
Journal:  Biomed Res Int       Date:  2022-02-07       Impact factor: 3.411

10.  Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics.

Authors:  Marc Hafner; Laura M Heiser; Elizabeth H Williams; Mario Niepel; Nicholas J Wang; James E Korkola; Joe W Gray; Peter K Sorger
Journal:  Sci Data       Date:  2017-11-07       Impact factor: 6.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.